Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winston Dunn

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Current Gastroenterology Reports|July 22, 2025
Resmetirom for Steatotic Liver Disease: Does Data Support Widespread Use?Winston Dunn, Naim Alkhouri
The American Journal of Gastroenterology|June 6, 2013
Response to Doganay et alWinston Dunn, Steven Weinman
Journal of Hepatology|February 24, 2015
Is it worthy of switching to PegIFN alfa-2a in patients achieving virological suppression with entecavir?Chuanghong Wu, Winston Dunn
Journal of Clinical and Experimental Hepatology|May 30, 2023
Determining Prognosis of ALD and Alcohol-associated HepatitisHeer Mehta, Winston Dunn
Translational Gastroenterology and Hepatology|October 18, 2019
Effect of alcohol consumption on nonalcoholic fatty liver diseaseGong Weng, Winston Dunn
Hepatology (Baltimore, Md.)|September 4, 2018
Advice Regarding Alcohol Use by Individuals With Nonalcoholic Fatty Liver Disease: Primum non nocereWinston Dunn, Naga Chalasani
Med (New York, N.Y.)|June 12, 2026
Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovationWinston Dunn, Naim Alkhouri
Clinics in Liver Disease|July 5, 2016
Pathogenesis of Alcoholic Liver DiseaseWinston Dunn, Vijay H Shah
Current Gastroenterology Reports|April 18, 2008
The obesity epidemic and nonalcoholic fatty liver disease in childrenWinston Dunn, Jeffrey B Schwimmer
Clinics in Liver Disease|April 6, 2023
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver DiseaseWinston Dunn, Laurent Castera, Rohit Loomba
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Current Gastroenterology Reports|July 22, 2025
Resmetirom for Steatotic Liver Disease: Does Data Support Widespread Use?Winston Dunn, Naim Alkhouri
The American Journal of Gastroenterology|June 6, 2013
Response to Doganay et alWinston Dunn, Steven Weinman
Journal of Hepatology|February 24, 2015
Is it worthy of switching to PegIFN alfa-2a in patients achieving virological suppression with entecavir?Chuanghong Wu, Winston Dunn
Journal of Clinical and Experimental Hepatology|May 30, 2023
Determining Prognosis of ALD and Alcohol-associated HepatitisHeer Mehta, Winston Dunn
Translational Gastroenterology and Hepatology|October 18, 2019
Effect of alcohol consumption on nonalcoholic fatty liver diseaseGong Weng, Winston Dunn
Hepatology (Baltimore, Md.)|September 4, 2018
Advice Regarding Alcohol Use by Individuals With Nonalcoholic Fatty Liver Disease: Primum non nocereWinston Dunn, Naga Chalasani
Med (New York, N.Y.)|June 12, 2026
Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovationWinston Dunn, Naim Alkhouri
Clinics in Liver Disease|July 5, 2016
Pathogenesis of Alcoholic Liver DiseaseWinston Dunn, Vijay H Shah
Current Gastroenterology Reports|April 18, 2008
The obesity epidemic and nonalcoholic fatty liver disease in childrenWinston Dunn, Jeffrey B Schwimmer
Clinics in Liver Disease|April 6, 2023
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver DiseaseWinston Dunn, Laurent Castera, Rohit Loomba
Pageof 7